Ysrraelit, María Célica
Fiol, Marcela Paula
Peña, Fernando Vazquez
Vanotti, Sandra
Terrasa, Sergio Adrián
Tran, Viet-Thi
Montori, Victor M.
Correale, Jorge
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (CFTY720DAR07T)
Article History
Received: 21 May 2019
Accepted: 21 August 2019
First Online: 27 August 2019
Ethics approval and consent to participate
: The protocol was approved by our local Ethical Committee: Comité de Etica en Investigación, Fundación Lucha Enfermedades Neurológicas de la Infancia (FLENI). All participants gave written informed consent.
: Not applicable
: In the last three years:Dr. Ysrraelit has received reimbursement for developing educational presentations, advisory boards and travel/accommodations stipends from Merck Argentina, Biogen, Sanofi-Genzyme, Bayer Inc., Roche and Novartis Argentina.Dr. Fiol has received reimbursement for developing educational presentations, advisory boards and travel/accommodations stipends from Merck Argentina, Biogen Argentina, Genzyme Argentina, Bayer Inc., Novartis Argentina and TEVA Argentina.Dr. Vasquez Peña has received reimbursement for research coaching presentations and travel/accommodations stipends by Fundación MF para el Desarrollo de la Medicina Familiar y la Atención Primaria, Argentina.Dr. S Vanotti has received reimbursement for developing educational presentations from Biogen Argentina and Novartis Argentina.Dr. Terrasa has received reimbursement for research coaching presentations and travel/accommodations stipends by Fundación MF para el Desarrollo de la Medicina Familiar y la Atención Primaria, Argentina.Dr. Tran has nothing to disclose.Dr. Montori has nothing to disclose.Dr. Correale is a board member of Merck-Serono Argentina, Novartis Argentina, Genzyme LATAM, Genzyme global, Biogen-Idec LATAM, and Merck-Serono LATAM. He is part of the Steering Committee for the clinical trials of Ofatumumab (Novartis Global). Dr. Correale has received reimbursement for developing educational presentations for Merck-Serono Argentina, Merck-Serono LATAM, Biogen-Idec Argentina, Genzyme Argentina, Novartis Argentina, Novartis LATAM, Novartis Global, and TEVA Argentina as well as professional travel/accommodations stipends.